 high-dos cytarabin intensif earli therapi childhood acut myeloid leukemia pediatr oncolog group studi june pediatr oncolog group pog pilot studi high-dos cytarabin hda intensif earli therapi childhood acut myelogen leukemia aml group remiss induct therapi cours daunorubicin cytarabin ara-c thioguanin dat postremiss therapi sequenti cours consist dose hda asparaginas l-asp etoposid VP azacytidin Az prednison vincristin methotrex mercaptopurin pomp ara-c daili day continu infus six dose intrathec ara-c cn prophylaxi decemb protocol group II dose hda second dat induct cours postinduct singl cours hda/l-asp cours remaind therapi unchang forti group patient group II patient assess group similar regard clinic prognost group signific differ group regard induct SE group induct death death remiss group cerebellar toxic patient group II none group present patient group II event-fre surviv patient group ef year SE SE disease-fre surviv df year SE SE differ signific group children year wbc outcom ef SE SE year children equal year wbc equal ef SE SE year